retatrutide trial doses produces up to 30.3% weight loss in Phase 3 Starting dose of retatrutide: the

Increased Nausea + GI Side Effects GLP-1s already cause: nausea reflux delayed stomach emptying bloating Wine and other alcohols can worsen: gastric irritation reflux vomiting stomach discomfort This is why many users naturally stop drinking (that's a GOOD THING

doi: 10.1136/dtb.2009.10.0046

Common reasons someone may not be eligible include: Personal or family history of medullary thyroid cancer (MTC) or MEN2 History of serious allergic reaction to the medication Certain pregnancy or breastfeeding situations (your clinician will advise) Specific GI conditions or prior pancreatitis may require extra caution GLP-1 dosing usually starts low and increases gradually to help your body adjust and reduce side effects

Both GIP secretion from GIP-producing cells [68, 97] and insulin secretion from pancreatic -cells in response to GIP [98] are enhanced in HFD-induced obese mice

Even if the solution appears normal, semaglutide should not be used past these timeframes, as potency degradation may occur without visible changes